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DNA replication is an extremely complex process that needs to be executed in a highly
accurate manner in order to propagate the genome. This task requires the coordination
of a number of enzymatic activities and it is fragile and prone to arrest after DNA damage.
DNA damage tolerance provides a last line of defense that allows completion of DNA
replication in the presence of an unrepaired template. One of such mechanisms is
called post-replication repair (PRR) and it is used by the cells to bypass highly distorted
templates caused by damaged bases. PRR is extremely important for the cellular life and
performs the bypass of the damage both in an error-free and in an error-prone manner.
In light of these two possible outcomes, PRR needs to be tightly controlled in order
to prevent the accumulation of mutations leading ultimately to genome instability. Post-
translational modifications of PRR proteins provide the framework for this regulation
with ubiquitylation and SUMOylation playing a pivotal role in choosing which pathway
to activate, thus controlling the different outcomes of damage bypass. The proliferating
cell nuclear antigen (PCNA), the DNA clamp for replicative polymerases, plays a central
role in the regulation of damage tolerance and its modification by ubiquitin, and
SUMO controls both the error-free and error-prone branches of PRR. Furthermore, a
significant number of polymerases are involved in the bypass of DNA damage possess
domains that can bind post-translational modifications and they are themselves target
for ubiquitylation. In this review, we will focus on how ubiquitin and ubiquitin-like
modifications can regulate the DNA damage tolerance systems and how they control
the recruitment of different proteins to the replication fork.
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INTRODUCTION
DNA damage poses a constant threat to the genetic material. It can arise from products either of
the cellular metabolism or by exposure to exogenous sources (physical or chemical). Regardless
of its origin, DNA damage is addressed swiftly by the multitude of repair mechanisms that
protect the integrity of the genome (Hoeijmakers, 2001). The DNA damage response provides an
overall control network for the repair mechanisms and it allows the coordination of the complex
biochemical reactions that lead to the elimination of DNA damage (Ciccia and Elledge, 2011).
Unfortunately, in certain conditions, the cells are exposed to an amount of damage that the repair
systems cannot handle completely. This could be caused either by an extreme insult, able to saturate
one or multiple repair systems, or by damage that is repaired slowly. The result of both conditions
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is the permanence of lesions in the template DNA. Nevertheless,
the damaged template then must be replicated during S
phase. Replicative DNA polymerases are extremely efficient and
processive but are unable to cope with a distorted template caused
by DNA damage. To solve this impasse, cells possess damage
tolerance pathways that are tasked with the bypass of the damage,
which eventually will be repaired at a later stage (Sale et al., 2012).
Failure to bypass the damage is believed to be one of the main
causes of replication fork blocks, cell cycle arrest and eventually
cell death.
During S phase, the damaged template can be replicated by
either a special class of DNA polymerases, in a process called
DNA translesion synthesis (TLS), or by a damage avoidance
pathway that uses the sister chromatid as a template, in a
mechanism called template switch. TLS utilizes specialized low-
fidelity DNA polymerases (η, ι, κ, ζ, and Rev1), mostly belonging
to the Y-family, to bypass the damaged template, while template
switch is proposed to use a recombination-like mechanism.
A crucial difference between the two pathways is that the former
is potentially error-prone, while the latter is thought to be error-
free (Branzei and Foiani, 2007; Sale et al., 2012). Given this
background, the choice of pathway is extremely important in
order to bypass the damage with the lowest possible chance
of introducing mutations. Post-translational modifications play
a central role in controlling damage tolerance and, in the last
few years, emerging evidence has shown that ubiquitylation
and SUMOylation sit at a crucial crossroad that influences its
outcomes (Huang and D’Andrea, 2006; Bergink and Jentsch,
2009; Bekker-Jensen and Mailand, 2011; Mailand et al., 2013;
Pinder et al., 2013).
Ubiquitylation is a process that involves the addition of
ubiquitin to a target protein. This process is conserved in
all eukaryotes and it controls a variety of cellular functions,
ranging from protein degradation to cell cycle progression.
Ubiquitylation is reversible and utilizes three classes of
enzymes to target ubiquitin to a desired protein (Hershko and
Ciechanover, 1998). In the initial step, an ubiquitin activating
enzyme (E1) forms a thioester bond with ubiquitin. Afterward,
ubiquitin conjugating enzymes (E2) transfer the ubiquitin from
the E1 to the target protein, either directly or with the help of
an E3 ubiquitin ligase that confers specificity to its E2 partner.
Ubiquitin is normally attached via its C-terminus to lysines
on the target proteins. Once ubiquitin has been linked to its
target, it can be further modified by the addition of additional
ubiquitin moieties on one of the lysines that can be found on
ubiquitin itself: K6, K11, K27, K29, K33, K48, and K63 (Ikeda
and Dikic, 2008; Kulathu and Komander, 2012). The linkage
to the different lysines confers diverse structural properties to
the polyubiquitin chains, creating a different binding platform
for a variety of processes. For example, K48-linked chains have
a compact structure (closed chain) and they direct proteins
to degradation by the proteasome (Varadan et al., 2002). On
the other hand, K63 chains are linear and flexible and they
seem to have a more prominent role in mediating protein–
protein interactions (Varadan et al., 2004). SUMOylation shares
a similar activating pathway with ubiquitin but uses SUMO
(Small Ubiquitin MOdifier) as a substrate (Muller et al., 2001;
Hay, 2005). In most organisms, a single SUMO is present
but human cells express 4 different variants (SUMO1–4, Hay,
2005). Remarkably, while in the human genome we can find
between 10 to 35 ubiquitin E2s and hundreds of putativeE3
ubiquitin ligases have been predicted, this number is greatly
reduced in the case of SUMO, up to the point where UBC9
encodes the only known SUMO E2 (Hay, 2005). The aim of this
review is to highlight the crucial role of both ubiquitylation and
SUMOylation in the regulation of the DNA damage tolerance
pathways.
UBIQUITYLATION OF PCNA
A number of E2 and E3 enzymes has been known for a long time
to be involved in the replication of damaged DNA, among these
the proteins encoded by Rad6, Rad18, Ubc13, Mms2, and Rad5
in the yeast Saccharomyces cerevisiae (Jentsch et al., 1987; Bailly
et al., 1994, 1997; Xiao et al., 2000). All of these proteins have been
shown to ubiquitylate, in different ways, the PCNA, assigning to
PCNA a central role in the regulation of damage bypass during
replication (Hoege et al., 2002; Mailand et al., 2013).
Proliferating cell nuclear antigen is a homotrimeric protein
that acts as the processivity factor for DNA polymerases, in a
role similar to E. coli β-clamp (Kuriyan and O’Donnell, 1993;
Krishna et al., 1994a,b). Each subunit consists of two different
domains connected by an interdomain connecting loop (IDCL).
The IDCL makes contacts and tethers the DNA polymerases to
the DNA. The binding to the IDCL of PCNA is mediated by a
PCNA interacting peptide (PIP) motif present in the interacting
partner. PCNA plays also crucial roles as a loading platform
for a variety of proteins involved in different repair systems
(Freudenthal et al., 2010; Dieckman et al., 2012). In yeast, PCNA
was originally discovered to be ubiquitylated after the treatment
with methyl methanesulfonate (MMS) by the complex formed by
the ubiquitin ligase Rad18 and the ubiquitin conjugating enzyme
Rad6 (Hoege et al., 2002) (Figure 1). Ubiquitylation was shown
to be attached to lysine 164 that is located on the back side of
the trimer, on the opposite side where the replicating polymerases
make contact (front side, Freudenthal et al., 2010).
Once monoubiquitylated, PCNA (Ubi-PCNA) can be further
modified resulting in the formation of K63-linked polyubiquitin
chains (Hoege et al., 2002). The two modifications were
proposed to channel the bypass toward different branches of
damage tolerance, with monoubiquitylation leading to TLS and
polyubiquitylation of PCNA steering the system toward template
switch (Branzei, 2011; Giannattasio et al., 2014).
Orthologs of all the proteins involved in the process
originally described in S. cerevisiae have been identified in both
invertebrates and vertebrates and, overall, the system appears
to be conserved across different organisms, although subtle
differences are present. For example, in Xenopus laevis, PCNA
is monoubiquitylated during an unperturbed S phase and this
modification is required for the efficient progression of the
replication fork in egg extracts, while polyubiquitylation of the
trimer appears specifically only after DNA damage (Leach and
Michael, 2005).
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FIGURE 1 | Schematic model of ubiquitin and ubiquitin-like modifications in the DNA damage tolerance pathway. (A) Monoubiquitylation of PCNA leading
to TLS. (B) Polyubiquitylation of PCNA leading to template switch. (C) ISGylation of PCNA and recovery from TLS. (D) SUMOylation of PCNA during unperturbed S
phase and inhibition of Homologous Recombination. Dotted lines indicate interactions between regulators of the DDT and modified/unmodified PCNA.
In vertebrates, the main modification of PCNA is
monoubiquitylation. It is observed after treatments that
block the progression of the replication fork (Kannouche and
Lehmann, 2004; Kannouche et al., 2004; Watanabe et al., 2004).
In such conditions, it is possible to detect an accumulation of
single-stranded DNA (ssDNA), likely caused by the uncoupling
of the activities of the blocked replication fork and the DNA
helicase. At this point, RPA readily binds the free ssDNA creating
the substrate for the recruitment of Rad18 and Rad6 that
ubiquitylate PCNA on lysine 164 (Davies et al., 2008). Rad18 and
replication protein A (RPA) interact directly and the recruitment
of Rad6/Rad18 to RPA-coated ssDNA has been observed in vitro
(Huttner and Ulrich, 2008). Monoubiquitylated PCNA has
increased affinity for TLS polymerases, whose interactions
are mediated by their PIP-boxes (PCNA-interacting peptide)
and ubiquitin-binding motifs (Kannouche et al., 2004; Bienko
et al., 2005; Dikic et al., 2009). Upon fork stalling, replicative
polymerases slow down and dissociate from the replisome
followed by the recruitment of TLS polymerases (polymerase
switching; Figure 1A). In the last few years, there has been
a progressive discovery of new factors that help Rad18 in
promoting the efficient ubiquitylation of PCNA. One of these
factors is a TLS polymerase itself. It is interesting to point out
that originally the recruitment of TLS polymerases was proposed
to be an event that followed the monoubiquitylation of PCNA.
New experimental data seem to suggest that TLS polymerases
can influence themselves the state of PCNA, and an increase
in PCNA ubiquitylation has been observed, in some cell types,
after polη overexpression (Durando et al., 2013; Masuda et al.,
2015). In these conditions, polη is believed to enhance and
stabilize Rad18 in the proximity of PCNA. Rad18 and polη have
been purified as a stable complex and their interaction has been
proposed to be dependent on the phosphorylation of Rad18.
Rad18 is phosphorylated, at a basal level even in unperturbed
conditions but this modification is enhanced after DNA damage
by DDK (Dbf4/Drf1-dependent Cdc7 kinase) and JNK (c-Jun
N-terminal kinase; Day et al., 2010; Barkley et al., 2012). This
hyper-phosphorylation is believed to increase the affinity of
Rad18 for polη and promote their mutual recruitment to the
chromatin, leading to the ubiquitylation of PCNA. However,
this model of action is still controversial since it would make
the accumulation of Ubi-PCNA an event dependent on ATR
and Chk1, in contrast with previous established experimental
evidence that demonstrated that ubiquitylation of PCNA is
independent from both ATM and ATR kinases and their
respective DNA damage checkpoints (Chang et al., 2006; Davies
et al., 2008; Gohler et al., 2008; Niimi et al., 2008; Yang et al.,
2008). A cohort of new factors that have been found to interact
with Rad18 to promote efficient PCNA ubiquitylation include
NBS1 (Yanagihara et al., 2011), Claspin and Chk1 (Yang et al.,
2008), RPA (Davies et al., 2008), Spartan (see later in this review,
Centore et al., 2012; Davis et al., 2012; Juhasz et al., 2012;
Mosbech et al., 2012) and SIVA1 (Han et al., 2014).
In human cells, Rad18 is the principal E3 ligase that
monoubiquitylates PCNA, but avian DT40 cells lacking Rad18
(Rad18−/−) still show detectable levels of Ubi-PCNA, indicating
the existence of another E3 ligase (Arakawa et al., 2006; Simpson
et al., 2006). In fact, other minor pathways leading to the
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ubiquitylation of PCNA have been proposed also in S. cerevisiae
and in human cells under specific conditions. In human cells,
RNF8 and CRL4Cdt2 were identified as ubiquitin E3 ligases
of PCNA, although their contribution is rather minor when
compared to Rad18 (Zhang et al., 2008; Terai et al., 2010).
Rad18 is itself ubiquitylated and its modification is believed to
control its availability and cellular localization. Rad18 has been
reported to form a homodimer where the ubiquitin moiety on
each Rad18 interacts with the UBZ (ubiquitin-binding zinc finger
domain) of the other subunit (Miyase et al., 2005; Notenboom
et al., 2007). Once Rad18 is de-ubiquitylated, it becomes active.
The Rad18 dimer, which is considered inactive, is believed
to localize mainly in the cytoplasm, while the active Rad18
monomer is distributed in the nucleoplasm. Recently, Rev1 has
been shown to bind ubiquitylated Rad18 causing the release
of non-modified Rad18 from the dimer, that is then free to
ubiquitylate PCNA on the chromatin (Wang et al., 2016). This
is another example of the extensive crosstalk between TLS
polymerases, Rad18 and PCNA, further strengthening the idea
that the regulation of DNA damage tolerance is far from a simple
linear pathway.
Once ubiquitylated, PCNA can be further modified via
K63-linked polyubiquitylation. In yeast, the complex formed
by Ubc13-Mms2 (E2) and Rad5 (E3) is responsible for this
modification (Hoege et al., 2002; Parker and Ulrich, 2009). In
human cells, polyUbi-PCNA is hardly observed in comparison
to yeast (Chiu et al., 2006) although all the proteins involved
are believed to be conserved. Two Rad5 orthologs have been
identified: helicase-like transcription factor (HLTF) and SNF2
histone linker PHD RING helicase (SHPRH; Figure 1B). HLTF
is characterized by ATPase and HIRAN domains that promote
fork regression in vitro, a crucial step in the stabilization of
the replication fork in the presence of DNA damage (MacKay
et al., 2009; Blastyak et al., 2010; Achar et al., 2015). Both HLTF
and SHRPH can catalyze the addition of ubiquitin chains to
Ubi-PCNA in vitro and their silencing, mediated by siRNA,
results in a decrease in polyUbi-PCNA in living cells (Motegi
et al., 2006, 2008; Unk et al., 2008, 2010). Recent evidence
suggests that the loss of HLTF and SHPRH increases mutagenesis
induced by UV and MMS treatment, respectively (Lin et al.,
2011). HLTF has been shown to have also a role in the mono-
ubiquitylation of PCNA and in the recruitment of polη (Lin
et al., 2011). Surprisingly, mouse embyonic fibroblast (MEF) cells
lacking both SHPRH and HLTF are still competent for PCNA
polyubiquitylation and the double mutant is not hypersensitive
to DNA-damaging agents (Krijger et al., 2011a). This seems to
suggest the existence of yet another E3 ligase involved in PCNA
ubiquitylation, at least in mouse. In light of all of this evidence,
it is clear that further investigation will be required in order to
understand the role of the Rad5 orthologs in higher eukaryotes.
GOING BACK: THE DE-UBIQUITYLATING
ENZYMES
Ubi-PCNA plays a central role in the bypass of damaged DNA
by facilitating the access of TLS polymerases to the replication
fork. However, unscheduled recruitment of low-fidelity TLS
polymerases would result in replication errors and mutagenesis
on undamaged DNA, thus the level of Ubi-PCNA must be strictly
controlled. Ubi-PCNA in human cells is negatively regulated
by the ubiquitin-specific protease 1 (USP1; Huang et al., 2006)
(Figure 1A). USP1 interacts with the activating protein partner
UAF1 (USP1-associated factor 1) and de-ubiquitylate Ubi-PCNA
in the absence of DNA damage (Cohn et al., 2007). USP1 is
subjected to an auto-cleavage reaction, which regulates its cellular
concentration (Cohn et al., 2007). Furthermore, high doses of
UV-C light result in the down-regulation of the USP1 transcript,
thus ensuring its down-regulation when the ubiquitylation of
PCNA needs to be promoted (Huang et al., 2006). Indeed, Ubi-
PCNA levels correlate nicely with the reduced expression levels
of USP1 after UV treatment (Niimi et al., 2008). Differently from
UV, USP1 is still present after hydroxyurea or MMS treatment,
two genotoxic agents that induce a strong ubiquitylation of
PCNA (Niimi et al., 2008). This observation suggests the possible
presence of other negative regulators.
USP1 has been shown to protect the cells from genomic
instability, as monitored by the formation of micronuclei, caused
by the erroneous recruitment of polκ and the following decrease
in fork progression (Jones et al., 2012). USP1 was the first
and most prominent DUB involved in the negative regulation
of PCNA ubiquitylation; however, recent data seem to suggest
the involvement of more DUBs in the control of PCNA. Some
of these DUBs either act directly on PCNA or can regulate
other proteins that control its ubiquitylation. Among these,
USP7, also called HAUSP, is the DUB that controls the stability
of p53 by counteracting the activity of Mdm2, the E3 ligase
responsible for its degradation (Li et al., 2002; Cummins and
Vogelstein, 2004; Sheng et al., 2006). Recently USP7 has been
shown to regulate indirectly the ubiquitylation of PCNA via the
stabilization of either Rad18 or polη (Qian et al., 2015; Zlatanou
et al., 2016). Other work has shown that USP7 can de-ubiquitylate
Ubi-PCNA in vitro and it suppresses UV- and oxidative-stress-
induced PCNA monoubiquitylation in vivo (Kashiwaba et al.,
2015). PCNA ubiquitylation after DNA damage is normally very
stable and can be detected days after the original genotoxic
treatment (Niimi et al., 2008). Another DUB involved in the de-
ubiquitylation of PCNA is USP10. USP10 can interact directly
with PCNA via its PIP box and its silencing results in increased
Ubi-PCNA 24 h after UV irradiation (Park et al., 2014). The
activity of USP10 is remarkably deferred compared with USP1
as no difference could be appreciated in the levels Ubi-PCNA
at 0 and 12 h after UV irradiation (Park et al., 2014), whereas
silencing of USP1 results in the accumulation of Ubi-PCNA
even in the absence of DNA damage (Huang et al., 2006). This
seems to suggest that USP10 may control the de-ubiquitylation
of Ubi-PCNA during the recovery from UV irradiation (see
ISGylation, later on). An USP1 ortholog has not been identified
in yeast. Recently, ubiquitin protease 10 (UBP10) was reported
to de-ubiquitylate Ubi-PCNA in S. cerevisiae (Gallego-Sanchez
et al., 2012). Cells lacking UBP10 accumulate Ubi-PCNA in
response to DNA damage resulting in an increased interaction
between PCNA and Rev1. UBP10 appears to de-ubiquitylate Ubi-
PCNA during S phase and its protein levels remain constant
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after UV treatment suggesting that UBP10 in yeast and USP1
in human regulate the de-ubiquitylation of PCNA by different
mechanisms (Gallego-Sanchez et al., 2012).
NEW READERS OF UBIQUITYLATED
PCNA
Once PCNA is ubiquitylated, it provides a loading platform for
a variety of proteins involved in the replication of damaged
DNA. As already mentioned, Ubi-PCNA can recruit a plethora
of TLS polymerases allowing damage bypass and the restart of
a stalled replication fork (Sale et al., 2012). Recently at least two
new proteins have been described to be able to read the state of
ubiquitylated PCNA and to help in maintaining the stability of
the fork: Spartan, also called DVC1, and ZRANB3 (Centore et al.,
2012; Davis et al., 2012; Mosbech et al., 2012) (Figures 1A–C).
Spartan is a substrate of the anaphase promoting complex and
localizes to replication factories in a manner dependent on both
its PIP and UBZ domains (Davis et al., 2012; Mosbech et al.,
2012). In its absence, cells become hypersensitive to DNA damage
agents and they are deficient in the DNA damage tolerance
(DDT) response. Spartan can bind to p97 via its SHP domain
(Davis et al., 2012; Mosbech et al., 2012). p97 encodes for a
chaperone protein that can remodel ubiquitylated proteins in an
ATP-dependent manner (Meyer et al., 2012).
As mentioned, Spartan PIP box and UBZ domain are needed
for its accrual in replication factories and DNA damage foci.
While all the data in the literature consistently report that PCNA
is required for Spartan recruitment, the role of Ubi-PCNA as the
target of Spartan’s UBZ is still controversial. Spartan can bind
Ubi-PCNA in vitro (Centore et al., 2012) but there are discording
evidences that this may occur in vivo. Two groups reported that
Spartan could relocalize to replication factories when Rad18 is
depleted by siRNA, a condition that results in the absence of
Ubi-PCNA (Davis et al., 2012; Mosbech et al., 2012). Spartan
itself is ubiquitylated and this modification prevents further
binding to ubiquitin targets and decreases its accumulation in
focal structures (Centore et al., 2012).
Given all the conflicting evidence, the role of Spartan is still
under scrutiny, with at least two proposed models of actions. In
the first Spartan is thought to bind to Ubi-PCNA and to promote
both Rad18 and polη recruitment to the chromatin. Its binding
would shield Ubi-PCNA from being de-ubiquitylated by USP1
or by another DUB, and in its absence PCNA ubiquitylation
appears to be reduced (Centore et al., 2012) (Figure 1A). At the
opposite side of the spectrum, an alternative mechanism proposes
Spartan acting as a negative regulator of TLS. In this scenario,
Spartan is thought to recruit p97, which in turn will remove
polη from the replication fork in order to resume processive
replication (Figure 1C). This model is substantiated by increased
focal retention of polη and increased mutagenesis when Spartan
is silenced (Davis et al., 2012; Mosbech et al., 2012). Recently,
three patients showing early onset hepatocellular carcinomas
and progeroid syndrome have been found to carry a mutation
in SPRTN (Lessel et al., 2014). When Spartan was mutated or
depleted, the cells showed signs of genomic instability, defects in
replication fork progression and cell proliferation. Interestingly,
depletion of polη in a background mutated in SPRTN did
not rescue the replication phenotypes, indicating that polη is
potentially not the main target of Spartan activity (Lessel et al.,
2014). The discovery of this new progeroid syndrome further
stresses the importance of SPRTN, but additional investigation is
needed to clarify the mechanism of action of this protein essential
for the DDT.
Proliferating cell nuclear antigen polyubiquitylation is
proposed to channel the DDT to an error-free damage avoidance
branch named template switch (Hoege et al., 2002; Branzei and
Foiani, 2007; Branzei, 2011). The molecular mechanism of this
pathway is still not completely understood and, until recently, we
did not know the role of K63-linked chains attached to PCNA.
In the last couple of years the protein ZRANB3/AH2, has been
proposed to be able to recognize specifically polyubiquitylated
PCNA and to promote template switch by stimulating fork
regression (Ciccia et al., 2012; Weston et al., 2012; Yuan et al.,
2012). ZRANB3 encodes for an annealing helicase/translocase
and it can interact with polyUbi-PCNA via multiple domains.
A canonical PIP motif and an APIM (C-terminal AlkB2 PCNA-
interaction motif) domain mediate the direct interaction with
the PCNA trimer while an NPL4 zinc finger (NZF), a variant
of ubiquitin-binding domain, recognizes K63-linked ubiquitin
chains specifically (Ciccia et al., 2012). This domain is able
to bind to polyUbi-PCNA in vitro and it is needed for the
localization of ZRANB3 to damage sites. All these structural
motifs are required for restarting the fork after DNA damage
(Figure 1B).
Experimental observations suggest that ZRANB3 may play
three different roles at the stalled replication fork: (1) it can
stimulate fork regression in order to stabilize the fork and
minimize the amount of ssDNA that is generated (Ciccia et al.,
2012). (2) ZRANB3 can disrupt D-loop formation in vitro and
this in turn could result in the prevention of inappropriate
homologous recombination (HR) (Ciccia et al., 2012); (3) it can
act as a strand-specific endonuclease pointing to a role not only
in damage bypass but also in damage repair (Weston et al., 2012).
ZRANB3 may act in parallel or in conjunction with HLFT
that also has a helicase activity and can stimulate fork regression
in vitro (Blastyak et al., 2010; Achar et al., 2015). Further work
will be needed in the future to completely elucidate ZRANB3 role
in damage tolerance and repair.
PCNA SUMOylation AND ISGylation
Another prominent post-translational modification of PCNA is
its SUMOylation. It was originally identified in yeast and only
recently it was observed in human cells.
In yeast, PCNA is SUMOylated (S-PCNA) on Lys164 (major)
and Lys127 (minor) by the combined action of Ubc9 (E2) and
Siz2 (E3) or by Ubc9 alone, respectively (Hoege et al., 2002)
(Figure 1D). SUMOylation occurs during normal S phase and/or
in response to high doses of DNA damage (Juhasz et al., 2012).
SUMOylated PCNA interacts with Srs2 helicase, which has been
shown to prevent HR by disrupting Rad51 filaments (Papouli
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et al., 2005; Pfander et al., 2005). Srs2 has a non-canonical PIP-
box with limited affinity for PCNA and it binds stably only when
the clamp is SUMOylated. A SUMO interacting motif that is
located in tandem after the PIP in the protein carboxyl terminus
of Srs2 mediates this interaction (Kim S.O. et al., 2012).
Given the catalytic activity of Srs2 and the timing of this
modification, it is believed that SUMOylation of PCNA acts as
a negative regulator of unscheduled HR during S phase, where
this kind of pathway could be detrimental to the cell. In yeast,
one of the replication factor C (RFC)-like complexes, Elg1-RFC
also has a role in regulating S-PCNA. RFC is a complex consisting
of Rfc1-5 and it works as clamp loader/unloader. All eukaryotic
cells contain a series of three alternative RFCs, containing Elg1,
Ctf18, or Rad24 in place of Rfc1(Kim and MacNeill, 2003). Elg1-
RFC is required for the efficient unloading of SUMOylated PCNA
from the chromatin during S phase. In cells lacking Elg1, PCNA
accumulates on the chromatin and it is possible to detect an
increase in SUMOylated PCNA (Parnas et al., 2010; Kubota et al.,
2013b).
In X. laevis S-PCNA is present during unperturbed replication
in cell extracts, but it is not required for the replication of either
ssDNA or sperm chromatin (Leach and Michael, 2005).
In human cells, S-PCNA had eluded detection for a number of
years and it has been detected only recently after overexpression
of SUMO1, although to a much less extent than the levels
detected in yeast (Moldovan et al., 2012). PCNA was found
to be SUMOylated on both Lys164 and Lys254 under specific
conditions (Gali et al., 2012). As in yeast, mammalian UBC9
acts as the E2 enzyme but surprisingly, at least in vitro, the
SUMOylation of PCNA does not require the Siz1 orthologs
(PIAS1-4) in either lysine residues (Gali et al., 2012).
A PCNA-SUMO fusion protein not only prevents HR, but
also DNA double-strand break formation, as monitored by
a marked reduction of γH2AX foci (Gali et al., 2012). Two
putative functional homologs of Srs2 have been identified in
human cells: PCNA-associated recombination inhibitor (PARI;
Moldovan et al., 2012) and F-box DNA helicase (FBH1; Fugger
et al., 2009; Bacquin et al., 2013). Both PARI and FBH1 have been
reported to interact with PCNA and to have PCNA-dependent
anti-recombinogenic activity, but only PARI seems to specifically
interact with SUMOylated PCNA, at least in vitro (Moldovan
et al., 2012). On the other hand, FBH1 needs to be degraded, via
CRL4Cdt2 pathway in order to allow efficient recruitment of polη
to replication factories (Bacquin et al., 2013).
In human cells, ATAD5, the ortholog of yeast Elg1 appears
to have a somehow different role from its yeast counterpart as
it interacts, at stalled replication forks, with the USP1/UAF1
complex and facilitates USP1-mediated PCNA de-ubiquitylation
(Lee et al., 2010; Kubota et al., 2013a).
Last year ISGyaltion, another ubiquitin-like modification, was
discovered to affect PCNA.
ISG15 (interferon-stimulated gene 15) was the first identified
ubiquitin-like protein and it is strongly stimulated by type I
interferon (Haas et al., 1987; Loeb and Haas, 1992). As ubiquitin
and SUMO this post-translational modification relies on a chain
of three classes of enzymes to be linked to its substrates: UBE1L is
the activating E1 enzyme, followed by UBCH8 (E2) and finally by
EFP and HERC5 (E3s; Yuan and Krug, 2001; Kim et al., 2004;
Zhao et al., 2004; Dastur et al., 2006; Zou and Zhang, 2006).
PCNA was reported to be bi-ISGylated 24 h after UV irradiation
by EFP on both K164 and K168 (Park et al., 2014). Mutations
of either residues resulted in the complete disappearance of
ISGylated PCNA indicating that ISGylation at one site influences
the state of the other. The late response to UV irradiation
suggested that ISG15 had a role in the recovery from DNA
damage and post-replication repair (PRR). The E3 ligase EFP
interacts with Ubi-PCNA and this interaction is propaedeutic to
PCNA ISGylation (Park et al., 2014). This modification in turn
recruits USP10 that de-ubiquitylates PCNA in order to block
TLS and resume normal replication. Eventually, UBP43 removes
ISG15 from PCNA (Figure 1C). ISGylation-deficient mutants
of PCNA show increased recruitment of polη to the chromatin
many hours after UV irradiation (Park et al., 2014).
UBIQUITYLATION OF TLS
POLYMERASES
As mentioned before, PCNA is not the only player that is
modified in order to control PRR. All the members of the
Y-family of DNA polymerase (η, ι, κ, and Rev1) involved in
DNA TLS have been identified to be modified by ubiquitin
or ubiquitin-like modifiers (Sale et al., 2012). Furthermore, all
four of them contain ubiquitin-binding domains (UBM or UBZ;
(Bienko et al., 2005; Guo et al., 2006, 2008; Plosky et al., 2006).
Probably, the best characterized of the group is polη, the
major TLS polymerase involved in the error-free bypass of
cyclobutane pyrimidine dimers (CPDs), the main adduct created
by UV irradiation. CPDs are repaired slowly by the nucleotide
excision repair (NER) and have a higher probability to persist
in the genome until DNA replication. The importance of the
bypass performed by polη is exemplified by the fact that
individuals carrying an inactivating mutation are affected by
Xeroderma pigmentosum Variant (XPV; Masutani et al., 1999).
Regardless of the importance of its function, polη shares a
common characteristic with other Y-family polymerases, a wide
catalytic site. This structural feature, while beneficial for damage
bypass, makes the polymerase intrinsically error-prone compared
to replicating polymerases when using undamaged DNA as a
template. For this reason, its recruitment to the replication fork
needs to be tightly regulated. Polη is recruited to replication
factories in a manner dependent on its PIP-box and UBZ, a
specialized ubiquitin-binding zinc finger (Kannouche et al., 2001,
2002; Bienko et al., 2005, 2010; Sabbioneda et al., 2009). The
presence of both domains stabilizes the interaction between
the polymerase and Ubi-PCNA after DNA damage (Kannouche
et al., 2004; Bienko et al., 2010). Mutants in either the PIP-
box or the UBZ are required for focal accumulation of the
polymerase but they retain a partial bypass activity, indicating
that they work in parallel to ensure efficient binding with
PCNA (Bienko et al., 2010). Ubiquitylation of PCNA provides a
positive regulation by increasing the affinity between polη and
the clamp when the replication fork is blocked (Kannouche et al.,
2004).
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Conversely, ubiquitylation of the polymerase works as
a negative regulator by preventing its recruitment on the
chromatin (Bienko et al., 2010). In vivo, a small amount of
polη is monoubiquitylated, in the absence of damage, in its
nuclear localization signal directly adjacent the PIP-box. The
modification occurs primarily on K682 but in its absence, also
K686, K694 and K709 have been found to be ubiquitylated
(Bienko et al., 2010; Jung et al., 2011). Ubiquitylation is strictly
dependent on the UBZ of polη. Recently, PirH2 was discovered
to be the E3 ligase responsible for this monoubiquitylation
(Jung et al., 2011). Ubiquitylation of polη is believed to cause
a conformational change in its C-terminus with the attached
ubiquitin binding intra-molecularly to polη’s UBZ. In this
closed confirmation, neither the UBZ, blocked by the binding
to the ubiquitin attached to polη, nor the PIP-box, that is
located between the UBZ and K682, are available to stabilize its
interaction with PCNA (Bienko et al., 2010). Ubi-polη is indeed
excluded from the chromatin and replication foci. After DNA
damage, ubiquitylated polη gradually disappears. The polymerase
can be then recruited to the chromatin and it becomes proficient
for TLS. The de-ubiquitylation of the polymerase is believed
to be carried out by the DUB USP7 (Qian et al., 2015). It is
important to note that only 10% of polη is ubiquitylated in the
absence of damage at any given time, indicating that some other
forms of regulation are keeping polη under negative control. In
some cellular background, polη gradually disappears in the hours
following UV irradiation. This process is believed to be mediated
by Mdm2 that polyubiquitylate the polymerase and marks it for
proteasomal degradation (Jung et al., 2012). A similar system,
mediated by CRL4Cdt2 has also been observed in Caenorhabditis
elegans. Interestingly in this system, the degradation of polη is
prevented by its SUMOylation by the SUMO E3 ligase GEI-
17 (Kim and Michael, 2008). It is still unclear whether polη is
SUMOylated in human cells.
Similarly, to polη also its paralog polι is ubiquitylated (Bienko
et al., 2005; McIntyre et al., 2015). This polymerase is thought
to bypass lesions when polη is not present (Wang et al., 2007;
Vidal and Woodgate, 2009). In vitro, polι can bypass different
typologies of DNA adducts with different degrees of fidelity
(Washington et al., 2004a,b; Frank and Woodgate, 2007).
Polι is characterized by two UBMs that are needed for its
modification and correct localization in replication foci (Bienko
et al., 2005; Bomar et al., 2010). It is speculated that the
ubiquitylation of polι might be important for its interaction with
polη (McIntyre et al., 2013).
The deoxycytidyl transferase Rev1 possesses two UBMs
(Bomar et al., 2010) and gets ubiquitylated in vivo (Guo et al.,
2006; Kim H. et al., 2012). The UBMs are needed for the efficient
interaction with Ubi-PCNA (Guo et al., 2006; Wood et al.,
2007). In yeast, deletion of UBM2 severely affects UV-induced
mutagenesis, a pathway that is strictly dependent on TLS (Wood
et al., 2007; Terai et al., 2010). Mutations in Rev1’s UBMs make
the cells hypersensitive to UV in the DT40 system (Guo et al.,
2006). In chicken cells, Rev1 and its UBMs have been shown
to have a role in replication fork progression in the presence of
UV in a process that is independent from Ubi-PCNA (Edmunds
et al., 2008). Finally, Rev1 appears to be able to bind to the
Fanconi core complex via FAAP20 and this interaction is believed
to promote Rev1 recruitment to replication foci and ultimately
Rev1-dependent mutagenesis (Mirchandani et al., 2008; Kim H.
et al., 2012).
The last TLS polymerase that has been reported to be
ubiquitylated is polκ (Guo et al., 2008). Polκ is characterized by
two UBZ domains in its c-terminus (Bienko et al., 2005) that have
been reported to be important for the interaction with PCNA and
the localization in foci after UV irradiation (Guo et al., 2008).
Polκ has also been shown to be important for NER, and its repair
function depends on its UBZs (Ogi et al., 2010).
The role of polκ ubiquitylation is currently not clear but it
is likely to promote protein–protein interaction similarly to the
other members of the Y-family of DNA polymerases.
DNA DAMAGE TOLERANCE AND
CANCER
Post-replication repair and the damage tolerance systems provide
an essential safety mechanism that allows the completion of DNA
replication and it is an important pathway to preserve genome
stability. At the same time, it can act as a double-edged sword
since a number of its components, such as TLS polymerases,
are intrinsically error prone and can be a source of mutations if
they are not correctly regulated. Mutations are one of the major
driving forces that lead to cell transformation and tumorigenesis,
therefore it is important to define the contribution of PRR in the
context of cancer. The dichotomy of protection versus increased
risk is emblematic in the case of polη. As already mentioned in
this review, a deficiency in polη is the cause of XPV (Broughton
et al., 2002). Like other XP groups that are mutated in NER, XPV
patients are sensitive to sun light and are extremely prone to both
melanoma and non-melanoma skin cancers (Fassihi et al., 2016).
Polη is the main polymerase that is able to bypass CPDs in an
error-free manner and it possible to envisage that when missing,
its role is carried out by other TLS polymerases with different
degrees of fidelity.
In these cases, the ultimate and less than desirable outcome
would be the introduction of mutations that are responsible for
the transformation of the skin cells. It is important to note that
polη-deficient patients are the most prone to skin cancers among
the X. pigmentosum groups (Fassihi et al., 2016). XPV patients
tend to have milder skin phenotypes and are normally diagnosed
much later in their life, when they have already accumulated a
number of UV-induced mutations. This higher mutation load
correlates with the possibility of developing more skin tumors
in their adult life (Fassihi et al., 2016). In this context, it is clear
that polη protects the cells from cancer. On the other hand, the
survival capability conferred by this polymerase can be hijacked
to make tumors more resilient. In vitro, cells lacking polη are
more sensitive to cisplatin, one of the most used first line drug
in chemotherapy (Albertella et al., 2005a). Increased expression
of polη associates with worse prognosis and survival in a cohort
of patients suffering from non-small cell lung cancer patients
previously treated with platinum (Ceppi et al., 2009). Polη seems
also to be involved in the cellular response after treatment with
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nucleoside analogs, which are commonly used in the clinic as
cancer drugs (Chen et al., 2006). Interestingly, mutations in
polη are hardly found in patients with sporadic skin carcinomas
(Glick et al., 2006; Flanagan et al., 2007; Lange et al., 2011) but
its overexpression has been reported (Albertella et al., 2005b).
Polη ortholog, polι, has been found to be elevated in breast
cancer cells and in these cell lines a reduced mutation frequency
was recorded when the polymerase was depleted in vitro (Yang
et al., 2004). Furthermore, mutation in polι have been linked to
an increased predisposition of developing lung cancer in both
human (Sakiyama et al., 2005) and mouse (Wang et al., 2004; Lee
and Matsushita, 2005).
Two of TLS polymerases extensively characterized for their
role in mutagenesis and cancer are polζ and Rev1. Polζ is thought
to be the major player involved in error-prone replication of
damaged templates in vivo. In mice, conditional Rev3 knockout
results in increased genome instability and tumorigenesis in a
p53-null background (Wittschieben et al., 2006, 2010; Lange
et al., 2013). Similarly to polη, there is experimental evidence
indicating that the presence of both Rev1 and polζ can confer
drug resistance both in vitro and in vivo (Xie et al., 2010).
Conversely, Rev3 inhibition makes lymphoma and lung cancer
cells more sensitive to platinum-derived drugs (Doles et al.,
2010), once again underlying the dichotomy of TLS regarding
cancer and genome protection. All of these evidences point to the
idea that transient inhibition of TLS could be synthetically lethal
to tumor cells that rely on the TLS mutator activity for survival.
TLS polymerases are not the only proteins involved in damage
tolerance that have been linked to cancer development. The
expression of the E3 ligase HLTF has been found to be altered in
transformed cells and in numerous tumors. A reduced expression
of HLTF, due to hyper-methylation of its promoter, has been
found in colon and colorectal cancer, esophageal squamous
cell and gastric carcinomas (Debauve et al., 2008). Interestingly
HLTF is overexpressed in transformed cells, indicating that a
differential modulation of its expression could be needed at
different stages of tumorigenesis (Debauve et al., 2008). Given
the role of HLTF in the control of the error-free branch of
damage tolerance, it is tempting to speculate that it could
be beneficial for tumor cells to inactivate HLTF in order to
channel the PRR pathway toward the more mutagenic TLS
bypass, thus allowing the malignant cells to accumulate more
mutations. As mentioned before a SPRTN deficiency has been
linked with a new progeroid syndrome with propensity to
develop early onset hepatocellular carcinomas, but it is still
not clear whether this phenotype is directly linked with its
proposed control of polη (Lessel et al., 2014). In conclusion,
a tight regulation of TLS and the DNA damage tolerance
pathway in general is required to preserve the delicate balance
between protecting the genome stability and inducing cellular
transformation.
THE UNANSWERED QUESTIONS
In the last decade, mounting evidence has pointed out the crucial
role of ubiquitin, and other ubiquitin-like modifications, in the
control of PCNA and TLS. Nevertheless, we still do not know
whether PCNA ubiquitylation is strictly required for TLS. A series
of experimental hints suggest that there is more to the story
and we still have only a partial picture of the regulation of
the damage tolerance pathway. For instance, MEF cells carrying
the PCNA K164R mutation can be further sensitized by the
deletion of other TLS genes, indicating that some steps of the
pathway could be independent from Ubi-PCNA (Hendel et al.,
2011). Furthermore, PCNA ubiquitylation is not required for
polη-mediated somatic hyper-mutation in mouse B cells (Krijger
et al., 2011b).
In human cells the phosphorylation of polη, that occurs
on the chromatin, is dependent on its UBZ, indicating
that the binding to ubiquitin is needed for this regulatory
modification (Gohler et al., 2011). However, this phosphorylation
does not require Ubi-PCNA and can occur in its absence
(Gohler et al., 2011). Dynamic studies on polη show
that Ubi-PCNA helps in stabilizing the polymerase in
replication foci but do not exclude the possibility that other
ubiquitylated proteins may play a role in its initial recruitment
(Sabbioneda et al., 2008). Consistent with this hypothesis
polη is still recruited to replication factories after chemical
depletion of Ubi-PCNA caused by prolonged treatment
with the proteasome inhibitors MG132 or epoxomicin
(Sabbioneda et al., 2008). It must be noted that mouse
cells carrying a homozygous K164R mutation appear to be
deficient for polη recruitment (Krijger et al., 2011b), and
so far no explanation has been found for these conflicting
evidences.
CONCLUSION
We are now starting to grasp the complexities of the
regulation of PRR and TLS, the continuous dance between
protein partners and the intricacies that lie behind such an
important tolerance pathway. Meanwhile, behind the scenes,
the hunt for the next big ubiquitylated/SUMOylated target still
rages on.
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